Axinn Represents Berkshire Partners in the Antitrust Aspects of its Acquisition of Forcura and Medalogix
March 19, 2025
Axinn successfully represented Berkshire Partners in the antitrust aspects of the parallel acquisitions of two post-acute care software companies: Forcura, an intelligent workflow management company; and Medalogix, a clinical decision support company. Together, the two complementary companies create a leading healthcare technology platform that brings real efficiencies and improved patient care, starting with home-based healthcare and expanding across the broader healthcare industry. Berkshire is the majority owner of the combined company.
The team was led by partners John Harkrider and Craig Minerva along with associates Laviana Alharmoosh, Josh Jowdy, and Megan Dill. The deal closed on March 19, 2025.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Informa CompLaw Antitrust West Coast Conference 2026
Speaking Engagement
Antitrust
ABA 2026 International Law Section Annual Conference
Speaking Engagement
Antitrust
No Games in Merger Review: DOJ Signals Discipline and Continuity
Axinn Viewpoints
Antitrust
I litigated the JetBlue-Spirit merger. A few thoughts on the future of antitrust in the airline industry
Byline Articles
Antitrust
2026 FDLI Annual Conference
Speaking Engagement
Intellectual Property
Let's Talk "About". . . That Bird?
Axinn Viewpoints
Intellectual Property
What’s on Antitrust Enforcers’ Minds? Federal and State Enforcer Perspectives on Health Care Transactions
Axinn Viewpoints
Antitrust
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust